Mizuho analyst Ann Hynes raised her price target for Universal Health Services to $150 after the company's 2019 trend outlook in both Acute care and Behavioral businesses fell in-line with her expectations. More importantly for the stock, Universal Health does not assume any return to EBITDA growth in the behavioral business, which reduces the risk to guidance provides for upside potential if patient length-of-stay stabilizes, Hynes tells investors in a research note. She keeps a Buy rating on the shares.
Barclays analyst Andrew Mok raised the firm's price target on Universal Health to $189 from $181 and keeps an Equal Weight rating on the shares post the Q1 report. The company posted broad pricing strength and strong acute inpatient volumes, which drove a big EBITDA beat, the analyst tells investors in a research note.
Check out this evening's top movers from around Wall Street, compiled by The Fly. HIGHER AFTER EARNINGSImpinj (PI) up... To see the rest of the story go to thefly.com. See Story Here